From Daejeon bioprocessing production center to your process: Building quality & regulatory confidence to APAC
Webinar
Gain confidence in Daejeon bioprocessing production center produced materials. Discover how our local manufacturing capabilities, robust quality systems, and Emprove® documentation can support product qualification and regulatory readiness across APAC.
By the end of this webinar, participants will be able to:
- Understand the Daejeon manufacturing capabilities and portfolio supporting APAC customers, including Cell Culture Media, Process Liquids/Buffers, and NovaSeptum®.
- Gain visibility into the quality systems, controls, and practices used to support product quality and consistency at Daejeon.
- Understand how Emprove® documentation can support material qualification and regulatory readiness.
Speakers
Dr. Christian Weber
Merck
Director, Upstream Manufacturing Network & Capabilities
Dr. Christian Weber holds a Ph.D. in Molecular Biology and an MBA. Since joining our company in 2012, he has held various roles in the field of cell culture, including Sales Specialist Consultant, Strategic Product Manager, and Global Franchise Lead for Cell Culture. He currently leads the strategic development of our company’s upstream manufacturing network and capabilities.
Michael Klement
Merck
Program Manager Emprove® SAFC Portfolio & CCM
As the Emprove® Program Manager for the SAFC® portfolio since 2023, Michael Klement, has focused on the ongoing development of Emprove® chemical dossiers content. In this role, he has led key initiatives including the nitrite statements launch and the rollout of lifecycle assessments. He joined our company in 1997 and has enjoyed various roles in Life Sciences. He holds an MBA from the University of Applied Sciences Darmstadt, Germany.
Munsang Lee
Merck
Head of Site Quality, Daejeon Bioprocessing Manufacturing Site
MunSang Lee brings over 25 years of experience in Quality Control and Quality Assurance (QC/QA) within the pharmaceutical and biopharmaceutical industries. Prior to joining the company, he served as a QA Principal Scientist at SK Biopharmaceuticals and as a QA Manager at Samsung Biologics. He currently serves as Site Quality Head for the company's new Bioprocessing Center in Daejeon, Korea.
Aria Kang
Merck
Regional Strategy Execution Manager - Downstream Process
Aria has diverse background in the broader pharmaceutical, clinical research, and life sciences industries that commenced with a degree in Biotechnology over a decade ago, her passion is to understand the needs and drivers of the market and deliver applicable Downstream solutions to customers.
Pharma and biopharma manufacturing
- Solid phase extraction
Duration:1h
Language:English
Session 1:Tue, November 24, 2026 2:00 PM SGT